Sustiva, Efavirenz Newswire (Page 4)

Sustiva, Efavirenz Newswire (Page 4)

Comprehensive Real-Time News Feed for Sustiva, Efavirenz (generic). (Page 4)

Results 61 - 70 of 70 in Sustiva, Efavirenz (generic)

  1. Second case report of PrEP failure due to drug-resistant virusRead the original story w/Photo

    Oct 18, 2016 | Aidsmap

    Our award-winning series of booklets, with each title providing a comprehensive overview of one aspect of living with HIV. A range of interactive tools to support people living with HIV to get involved in decisions about their treatment and care.

    Comment?

  2. EmtricitabineRead the original story w/Photo

    Oct 4, 2016 | Aidsmap

    Our award-winning series of booklets, with each title providing a comprehensive overview of one aspect of living with HIV. A range of interactive tools to support people living with HIV to get involved in decisions about their treatment and care.

    Comment?

  3. Effectiveness and safety of generic version of abacavir/lamivudine...Read the original story w/Photo

    Oct 2, 2016 | BioMed Central

    Generic drug policies are often associated with concerns about the quality and effectiveness of these products. Phase IV clinical trials may be a suitable design to assess the effectiveness and safety of generic drugs.

    Comment?

  4. Tuberculous spondylitis diagnosed through Xpert MTB/RIF assay in urine: a case reportRead the original story w/Photo

    Sep 25, 2016 | BioMed Central

    Extrapulmonary tuberculosis is associated with high rates of morbidity and mortality. Diagnosis of EPTB is challenging in resource-limited settings due to difficulties in obtaining samples, as well as the paucibacillarity of the specimens.

    Comment?

  5. Human Immunodeficiency Virus (HIV) - Brazil Drug Forecast, Industry...Read the original story

    Sep 24, 2016 | Emailwire.com

    Brazil Drug Forecast and Market Analysis to 2023 Size and Share Published in 2015-09-09 Available for US$ 4995 at Researchmoz.us Description Human immunodeficiency virus is a retrovirus that infects the cells of the immune system, destroying or impairing their function. As the infection progresses, the immune system becomes increasingly weaker, making the infected person more susceptible to other infections.

    Comment?

  6. Human Immunodeficiency Virus (HIV) - China Drug Forecast and Market...Read the original story

    Sep 24, 2016 | Emailwire.com

    Human immunodeficiency virus is a retrovirus that infects the cells of the immune system, destroying or impairing their function. As the infection progresses, the immune system becomes increasingly weaker, making the infected person more susceptible to other infections.

    Comment?

  7. Immune reconstitution inflammatory syndrome associated with...Read the original story w/Photo

    Sep 19, 2016 | BioMed Central

    Immune reconstitution inflammatory syndrome associated with dermatophytoses may cause considerable morbidity. Yet, it has been scarcely reported and is rarely considered in the differential diagnosis of HIV associated cutaneous lesions in Africa.

    Comment?

  8. Warning over morning-after pill as 400 unwanted pregnancies revealedRead the original story w/Photo

    Sep 15, 2016 | Independent.ie

    Women who take the morning-after pill are being warned that those taking common medications may need a double dose after research found 400 unwanted pregnancies. Women who take the morning-after pill are being warned that those taking common medications may need a double dose after research found 400 unwanted pregnancies.

    Comment?

  9. AIDS 2016: Infection Prophylaxis Reduces Risk of Death for People Starting HIV Treatment LateRead the original story w/Photo

    Aug 23, 2016 | HIV and Hepatitis

    A package of enhanced prophylaxis against infections significantly reduced the risk of death for adults and children with advanced HIV disease after starting antiretroviral treatment in a randomized study, James Hakim from the University of Zimbabwe reported at the 21st International AIDS Conference last month in Durban. Another analysis showed that intensifying treatment by adding raltegravir did not offer added benefits.

    Comment?

  10. German medicines watchdog rejects - new tenofovir' pillRead the original story w/Photo

    Aug 22, 2016 | Aidsmap

    Our award-winning series of booklets, with each title providing a comprehensive overview of one aspect of living with HIV. A range of interactive tools to support people living with HIV to get involved in decisions about their treatment and care.

    Comment?